免責事項:アナリストのレーティングおよび目標株価は、情報提供のみを目的としてLSEG Data & Analyticsが提供するものであり、投資助言を構成するものではありません。
Tandem Diabetes Care Incの注目ポイント
強みリスク
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
企業コードTNDM
企業名Tandem Diabetes Care Inc
最高経営責任者「CEO」Mr. John F. Sheridan
ウェブサイトhttps://www.tandemdiabetes.com/
よくある質問
Tandem Diabetes Care Inc(TNDM)の現在の株価はいくらですか?
Tandem Diabetes Care Inc(TNDM)の現在の株価は21.840です。
Tandem Diabetes Care Incのティッカーシンボルは何ですか?
Tandem Diabetes Care IncのティッカーシンボルはTNDMです。
Tandem Diabetes Care Incの52週高値はいくらですか?
Tandem Diabetes Care Incの52週高値は38.280です。
Tandem Diabetes Care Incの52週安値はいくらですか?
Tandem Diabetes Care Incの52週安値は9.980です。
Tandem Diabetes Care Incの時価総額はいくらですか?
Tandem Diabetes Care Incの時価総額は1.48Bです。
Tandem Diabetes Care Incの純利益はいくらですか?
Tandem Diabetes Care Incの純利益は-96.03Mです。
Tandem Diabetes Care Inc (TNDM) の現在の評価は「買い」、「ホールド」、「売り」のどれですか?
アナリストによると、Tandem Diabetes Care Inc(TNDM)の総合評価は中立で、目標株価は21.682です。
Tandem Diabetes Care Inc (TNDM) の1株当たり利益(EPS TTM)はいくらですか?
Tandem Diabetes Care Inc(TNDM)の1株当たり利益(EPS TTM)は-3.030です。